Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Keros Therapeutics filings provide 6 years of Asset Utilization Ratio readings, the most recent being 0.45 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 225179.88% to 0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45, a 225179.88% increase, with the full-year FY2025 number at 0.51, changed N/A from a year prior.
  • Asset Utilization Ratio hit 0.45 in Q4 2025 for Keros Therapeutics, up from 0.32 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.45 in Q4 2025 to a low of 0.0 in Q4 2024.
  • Median Asset Utilization Ratio over the past 5 years was 0.06 (2022), compared with a mean of 0.12.
  • Biggest five-year swings in Asset Utilization Ratio: crashed 146.3% in 2024 and later surged 225179.88% in 2025.
  • Keros Therapeutics' Asset Utilization Ratio stood at 0.07 in 2021, then dropped by 13.25% to 0.06 in 2022, then crashed by 99.33% to 0.0 in 2023, then tumbled by 146.3% to 0.0 in 2024, then surged by 225179.88% to 0.45 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.45 (Q4 2025), 0.32 (Q3 2025), and 0.3 (Q2 2025) per Business Quant data.